ArticleAmerican journal of cancer research2024

Effect of the thyroid transcription factor 1 expression and treatment discontinuation due to adverse events on progression-free survival in patients with advanced non-squamous non-small cell lung cancer treated with pembrolizumab plus pemetrexed and platinum chemotherapy: a Japanese four-hospital, retrospective study.

Shoma Mori et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.